慢性阻塞性肺病患者、政府资助的科学家和企业代表对药物发现研究中的责任和利益相关者参与的看法

IF 3.9 1区哲学 Q1 ETHICS

Journal of Responsible Innovation Pub Date : 2024-02-28 DOI:10.1080/23299460.2024.2316363

Zainab Afshan Sheikh, Helen Yu

引用次数: 0

摘要

在负责任的研究与创新（RRI）框架中，通过利益相关者的参与确保研究与创新的社会影响力至关重要。通过对一个药物发现项目的研究，我们了解了如何通过利益相关者的参与来确保研究与创新的社会影响力。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Perspectives of COPD patients, publicly funded scientists, and industry representatives on responsibility and stakeholder engagement in drug discovery research

Ensuring societal influence in research and innovation through stakeholder engagement is vital in the Responsible Research and Innovation (RRI) framework. By studying a drug discovery project, we e...

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Journal of Responsible Innovation Multiple-

CiteScore

8.60

自引率

20.50%

发文量

审稿时长

12 weeks

期刊介绍： The Journal of Responsible Innovation (JRI) provides a forum for discussions of the normative assessment and governance of knowledge-based innovation. JRI offers humanists, social scientists, policy analysts and legal scholars, and natural scientists and engineers an opportunity to articulate, strengthen, and critique the relations among approaches to responsible innovation, thus giving further shape to a newly emerging community of research and practice. These approaches include ethics, technology assessment, governance, sustainability, socio-technical integration, and others. JRI intends responsible innovation to be inclusive of such terms as responsible development and sustainable development, and the journal invites comparisons and contrasts among such concepts. While issues of risk and environmental health and safety are relevant, JRI especially encourages attention to the assessment of the broader and more subtle human and social dimensions of innovation—including moral, cultural, political, and religious dimensions, social risk, and sustainability addressed in a systemic fashion.